Ncardia is a leader in contract research, development and manufacture of iPSC-based solutions for early and preclinical drug discovery. Our goal is to enable pharmaceutical and therapeutics companies to make more confident decisions in discovery and development by integrating iPSC technologies into their screening processes.
Our capabilities include disease modeling, manufacturing, assay development and high-throughput screening, with a focus on (but not limited to) cardiac and neurodegenerative diseases.
